Sage Rhino Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $203K | Sell |
4,375
-149
| -3% | -$6.9K | 0.04% | 243 |
|
2025
Q1 | $276K | Buy |
4,524
+246
| +6% | +$15K | 0.06% | 177 |
|
2024
Q4 | $242K | Buy |
4,278
+56
| +1% | +$3.17K | 0.05% | 198 |
|
2024
Q3 | $218K | Buy |
+4,222
| New | +$218K | 0.05% | 230 |
|
2024
Q2 | – | Sell |
-3,884
| Closed | -$211K | – | 253 |
|
2024
Q1 | $211K | Sell |
3,884
-86
| -2% | -$4.66K | 0.05% | 204 |
|
2023
Q4 | $204K | Sell |
3,970
-187
| -4% | -$9.6K | 0.05% | 202 |
|
2023
Q3 | $241K | Sell |
4,157
-103
| -2% | -$5.98K | 0.07% | 176 |
|
2023
Q2 | $272K | Sell |
4,260
-292
| -6% | -$18.7K | 0.08% | 171 |
|
2023
Q1 | $315K | Buy |
4,552
+239
| +6% | +$16.6K | 0.09% | 154 |
|
2022
Q4 | $310K | Buy |
4,313
+74
| +2% | +$5.32K | 0.1% | 154 |
|
2022
Q3 | $301K | Sell |
4,239
-86
| -2% | -$6.11K | 0.12% | 128 |
|
2022
Q2 | $333K | Buy |
4,325
+72
| +2% | +$5.54K | 0.13% | 134 |
|
2022
Q1 | $311K | Sell |
4,253
-11
| -0.3% | -$804 | 0.09% | 160 |
|
2021
Q4 | $266K | Sell |
4,264
-3,682
| -46% | -$230K | 0.07% | 177 |
|
2021
Q3 | $470K | Buy |
7,946
+10
| +0.1% | +$591 | 0.14% | 112 |
|
2021
Q2 | $530K | Sell |
7,936
-2,238
| -22% | -$149K | 0.16% | 104 |
|
2021
Q1 | $642K | Buy |
10,174
+25
| +0.2% | +$1.58K | 0.21% | 85 |
|
2020
Q4 | $630K | Sell |
10,149
-89
| -0.9% | -$5.53K | 0.25% | 75 |
|
2020
Q3 | $617K | Sell |
10,238
-290
| -3% | -$17.5K | 0.3% | 66 |
|
2020
Q2 | $619K | Buy |
10,528
+209
| +2% | +$12.3K | 0.33% | 64 |
|
2020
Q1 | $575K | Buy |
10,319
+303
| +3% | +$16.9K | 0.41% | 51 |
|
2019
Q4 | $653K | Buy |
10,016
+4,931
| +97% | +$321K | 0.37% | 60 |
|
2019
Q3 | $258K | Buy |
5,085
+324
| +7% | +$16.4K | 0.16% | 113 |
|
2019
Q2 | $216K | Sell |
4,761
-66
| -1% | -$2.99K | 0.14% | 119 |
|
2019
Q1 | $230K | Buy |
+4,827
| New | +$230K | 0.15% | 110 |
|